NOT-DA-19-016: Notice of Correction to Application Types Allowed for RFA-DA-19-030, " Analytical Tools and Approaches for (Multidimensional) Scholarly Research Assessment and Decision Support in the Biomedical Enterprise (R41/R42

Notice of Correction to Application Types Allowed for RFA-DA-19-030, " Analytical Tools and Approaches for (Multidimensional) Scholarly Research Assessment and Decision Support in the Biomedical Enterprise (R41/R42 - Clinical Trial Not Allowed)"

Notice Number: NOT-DA-19-016

Key Dates
Release Date: January 4, 2019

Related Announcements

RFA-DA-19-030

RFA-DA-19-031

Issued by
National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this Notice is to change the Application Types Allowed for RFA-DA-19-030, "Analytical Tools and Approaches for (Multidimensional) Scholarly Research Assessment and Decision Support in the Biomedical Enterprise (R41/R42 - Clinical Trial Not Allowed)"

The following section has been modified:

Section II. Award Information

Currently reads:

Application Types Allowed

New (Phase I)

Renewal (Phase II and Direct Phase II allowed)
New (Fast-Track)

Should correctly read:

Application Types Allowed

New (Phase I)

New (Fast-Track)

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Irina Sazonova, PhD
National Institute on Drug Abuse (NIDA)
Telephone:301-827-5873
Email:[email protected]